- The report features descriptive drug profiles for the pipeline products which includes, product description,
descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Glioblastoma Multiforme (GBM) therapeutics and enlists all their major
and minor projects
- The report assesses Glioblastoma Multiforme (GBM) therapeutics based on drug target, mechanism of action
(MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Glioblastoma Multiforme (GBM)
Reasons To Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain
competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Glioblastoma
Multiforme (GBM)
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Glioblastoma Multiforme (GBM) pipeline
depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most
attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove
them from pipeline
Buy a Sample Copy of This Report @ http://www.radiantinsights.com/research/glioblastoma-multiforme-gbmpipeline-review-h1-2016/request-sample
Table of Contents
Table of Contents 2
Introduction 10
Glioblastoma Multiforme (GBM) Overview 11
Therapeutics Development 12
Glioblastoma Multiforme (GBM) - Therapeutics under Development by Companies 14
Glioblastoma Multiforme (GBM) - Therapeutics under Investigation by Universities/Institutes 30
Glioblastoma Multiforme (GBM) - Pipeline Products Glance 33
Glioblastoma Multiforme (GBM) - Products under Development by Companies 37
Glioblastoma Multiforme (GBM) - Products under Investigation by Universities/Institutes 57
Glioblastoma Multiforme (GBM) - Companies Involved in Therapeutics Development 61
Glioblastoma Multiforme (GBM) - Therapeutics Assessment 235
Drug Profiles 2